All stock lists
Aditxt, Inc. (OTC:ADTX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.00+0.00 (-25.00%)
Insider Score
––Not scored
ADTX Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
ADTX Income Statement
| Fiscal Period | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Period Ending | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 |
| Revenue | 12.16 K | 425.00 | 748.00 | 1.00 K | 1.02 K | 3.17 K |
| Revenue Growth (YoY) | 1094.40 % | -86.61 % | -89.09 % | -97.73 % | -98.72 % | -96.09 % |
| Cost of Revenue | 9.29 K | 456.00 | 732.00 | 1.00 K | 734.00 | 71.00 K |
| Gross Profit | 2.87 K | -31.00 | 16.00 | -1.00 | 284.00 | -67.83 K |
| SG&A Expense | 3.32 M | 4.12 M | 2.47 M | 5.39 M | 4.40 M | 4.89 M |
| R&D Expense | 1.05 M | 548.56 K | 672.04 K | 764.33 K | 1.21 M | 695.95 K |
| Operating Expenses | 4.36 M | 4.67 M | 3.14 M | 6.15 M | 5.61 M | 5.58 M |
| Operating Income | -4.36 M | -4.67 M | -3.14 M | -6.15 M | -5.61 M | -5.65 M |
| Pretax Income | -16.19 M | -5.23 M | -24.21 M | -7.40 M | -5.95 M | -5.55 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -15.95 M | -4.70 M | -24.05 M | -7.26 M | -5.71 M | -5.23 M |
| EPS (Basic) | -790.49 | -148.00 | -548.78 | -3.45 | -8.12 | -100.70 |
| EPS (Diluted) | -790.49 | -148.00 | -548.78 | -3.45 | -8.12 | -100.70 |
| Shares Outstanding | 20.17 K | 37.35 K | 43.82 K | 21.02 K | 70.37 K | 51.90 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.